Journal Information
Vol. 109. Issue 7.
Pages 579 (September 2018)
Vol. 109. Issue 7.
Pages 579 (September 2018)
Editorial Comments
Full text access
Biologic Therapy as a First-Line Treatment in Patients with Psoriasis: An Unstudied Population
Tratamiento biológico como primera línea en pacientes con psoriasis: una población no estudiada
Visits
3563
O. Baniandrés Rodríguez
Servicio de Dermatología, Hospital General Universitario Gregorio Marañón, Madrid, España
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text

The BIOBADADERM registry prospectively collects demographic data, clinical management data, and data on adverse events from 14 Spanish hospitals under conditions of daily clinical practice. Therefore, it is extremely useful for determining the therapeutic management of moderate to severe psoriasis in Spain.

In this article from the BIOBADADERM study group,1 the authors describe the clinical characteristics of patients who receive biologic drugs as first-line therapy in daily clinical practice. These are the first published data of this type, since, according to the summary of product characteristics, biologic drugs are usually prescribed after classic systemic treatments. Patients who receive biologics as first-line therapy more often have arterial hypertension, diabetes mellitus, chronic liver disease, hepatitis C, and HIV infection. Therefore, it seems that the main reason classic systemic options are ruled out as first-line therapy is to avoid associated interactions and adverse effects.

In contrast, there are no differences in clinical characteristics, medical management, or adverse effects between patients who receive biologics as first- or second-line therapy.

This study opens the debate on the advantages and disadvantages of biologic treatment as first-line systemic treatment before conventional therapy.

Reference
[1]
G. Carretero Hernández, C. Ferrándiz, R. Rivera Díaz, E. Daudén Tello, P. de la Cueva-Dobao, F.J. Gómez-García, et al.
Descripción de los pacientes que reciben biológicos como primer tratamiento sistémico en el registro de BIOBADADERM durante el periodo 2008-2016.
Actas Dermosifiliogr, 109 (2018), pp. 617-623

Please cite this article as: Baniandrés Rodríguez O. Tratamiento biológico como primera línea en pacientes con psoriasis: una población no estudiada. Actas Dermosifiliogr. 2018;109:579.

Copyright © 2018. Elsevier España, S.L.U. and AEDV
Idiomas
Actas Dermo-Sifiliográficas
Article options
Tools
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?